Our Braintree Manufacturing Innovation Centre (MIC) is a 4,627m2 facility uniquely equipped to help accelerate the development of GMP manufacturing operations for advanced therapies at a clinical and commercial scale. With aims to secure regulatory licensure in early 2024, our facility has the infrastructure to support your viral vector and cell and gene therapy manufacturing needs.
We provide the necessary expertise and resources for you to accelerate the development of your advanced therapy manufacturing processes through the clinic and on to commercialisation, with access to segregated cleanroom modules, state-of-the art-equipment, proven pharmaceutical quality control systems and over 100 trained staff with key skills in GMP manufacturing.
Through our flexible, collaborative approach, we help you to develop your own manufacturing capability operating within one of our modules and alongside our expert teams. They can support you in achieving your own clinical and commercial-scale cell and gene therapy manufacturing goals by bringing together innovative technologies, quality, operational excellence and analytical and technology transfer experience.
Get in touch!
Got an idea or innovation?
We're always searching for new companies to work with. Contact us today if you've got an idea, innovation, or would like to discuss how we can support your research.